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Condensation 
Background uterine EMG activity measure from the abdominal surface in mid trimester of 
pregnancy does not depend on placental implantation site. 
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Placental site does not change background uterine electromyographic activity in mid 
trimester of pregnancy 
Ozren Grgic, Ratko Matijevic, Oliver Vasilj 
 
Abstract 
Objective: This study was performed in order to assess the potential influence of placental 
implantation site on transabdominal electromyographic (EMG) assessment of the uterine 
electrical activity in mid trimester of pregnancy.   
Study design: In this prospective study 251 unselected, nulliparous asymptomatic women 
with singleton pregnancy underwent transabdominal uterine EMG. Uterine electrical activity 
was recorded using bipolar electrodes placed on the abdominal surface for 20 minutes. 
Regarding the placental implantation site and presence of action potentials (AP) pregnant 
women were divided into two groups: anterior placenta group (APG) and posterior placenta 
group (PPG).  Outcome measures were difference between median frequency (MF) and 
median amplitude (MA) of AP between the two groups. 
Results: Action potentials were detected in 56 women - APG 33/56 versus PPG 23/56. The 
analyzed parameters: MF (p =0.527, Fisher exact test) and MA (p =0.255, Fisher exact test) 
did not show any statistical significant difference between the two groups.  
Conclusion: Background uterine EMG activity measured from the abdominal surface in mid 
trimester of pregnancy does not depend on placental implantation site. 
Keywords: transabdominal electromyography (EMG), placenta, implantation site, uterine 
electrical activity, action potentials 
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Introduction  
Uterine electrical activity has been an important subject of interest during last decades, 
particularly after development of a new, noninvasive method for electrical assessment of the 
pregnant uterus - transabdominal uterine electromyography (EMG); and improved filtering 
system that reduces the recording artifacts [1, 2]. Electrical activity originates form the 
depolarization and repolarisation of thousands of smooth muscle myometrial cells [3]. 
Myometrial cells have two forms of electric potentials: resting membrane potential and action 
potential (AP) [4]. Gap junctions, used for inter cell communication, develop progressively 
with duration of pregnancy and play an important role in the electrical evolution of the 
myometrium [5, 6]. Action potentials have ability to spread unchanged trough gap junctions 
from one to another myometrial cell, causing increased and organized electrical activity [7]. 
Organized and synchronized electrical activity precedes mechanical activity which results in 
myometrial contractions [1, 8].  
Transabdominal uterine EMG can be used to assess electrical activity of pregnant uterus from 
mid trimester (16 - 18 week). The anterior uterine wall is the main origin of the uterine 
electrical activity detected trough the abdominal wall [1, 2].  
So far there have been no studies investigating the relationship of transabdominally recorded 
EMG activity of uterus and placental implantation site in mid trimester of pregnancy. Some 
investigators have reported that anterior placental implantation site causes changes in the 
electrical activity of the human uterus during the last trimester of pregnancy and labor [9 -12]. 
This phenomenon is based on the local hormonal inhibitory influence of the placenta on the 
surrounding myometrial cells [10, 11]. 
The aim of this study was to test the potential influence of the placental implantation site on 
the electrical uterine activity measured from the abdominal surface (transabdominal EMG) in 
low risk asymptomatic population of pregnant women in mid trimester of pregnancy. 
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Materials and methods 
This prospective study was performed between October 2002 and September 2004 at 
University Department of Obstetric and Gynecology, “Sveti Duh” Hospital, Zagreb, Croatia. 
The final results were based on 56 women with detected AP. Regarding the placental 
implantation site and presence of AP, pregnant women were divided into two groups: 33/56 in 
anterior placenta group (APG) and 23/56 in posterior placenta group (PPG).  
In order to select them, 251 nulliparous asymptomatic women with singleton pregnancy 
underwent transabdominal uterine EMG. Totally 138/251 women had placenta on the anterior 
uterine wall and 113/251 women had placenta on the posterior uterine wall. 
 This prospective cohort study was a part of a research project designed to assess the efficacy 
of different noninvasive diagnostic methods such as sonographic assessment of cervical 
length, qualitative sonographic assessment of cervical glands and mucus area and 
transabdominal uterine EMG as potential screening tests for preterm labor (PTL) and late 
spontaneous miscarriage (LSM) (Croatian Ministry of Science, Project No 0129111). During 
the study period, 346 women were approached in order to participate in the study. All of them 
were booked for in-hospital antenatal care from one consultant (RM) in low risk clinic. 
The entry criteria were: 1. nulliparous women with singleton pregnancies 16 0/7 – 23 6/7 
gestational weeks, 2. asymptomatic pregnancy, a) without clinical and laboratory evidence of 
infection (WCC < 14 x 1012/l, CRP < 10 mg/l), b) no evidence of infection on cervical and 
vaginal swabs and c) vaginal pH < 4,5. The exclusion criteria were uterine factors that could 
affect the distribution of electrical activity trough the myometrium, including; Műllerian duct 
anomalies, uterine fibromas, clinically palpable contractions, multiple pregnancy and 
presence of polyhydramnios. We excluded women with body mass index (BMI) > 25 kg/m2 
because the increased abdominal thickness reduces the detection of AP by transabdominal 
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EMG. Since spasmolytic or tocolytic drugs may decrease myometrial electrical activity, 
women using these drugs were also excluded.  
Based on the defined entry criteria 11 women were excluded because of WCC > 14 x 1012/l, 7 
were excluded because of CRP > 10 mg/l, while 18 women were excluded because the 
findings on cervical and vaginal swabs were different than the normal vaginal flora and 27 
were excluded  because the vaginal pH level was above 4,5. 
Prior to the entry, every woman signed informed consent form approved by hospital and 
national ethical committee. Totally 32 women did not give their consent for the study. 
Placental implantation site was determined by  transabdominal ultrasound scan (Aloka 5500, 
ALOKA CO. LTD, Japan). Transabdominal uterine EMG was performed on empty urinary 
bladder.   
Uterine EMG activity was detected using two bipolar surface silver-silver chloride disc 
electrodes (The 2-channel TECA™ Synergy T-EP system, Oxford Instruments, UK). The 
electrode sites of attachment were cleaned and treated with electrode gel. The bipolar 
electrodes were applied to the abdominal wall with adhesive tape symmetrically on both sides 
of the uterus. The electrodes were placed on abdominal projections of corneal and isthmic part 
of the uterus, while the reference electrode was placed on the woman’s right wrist. Each 
measurement lasted 20 minutes. The EMG activity was amplified, acquired and digitalized 
using TECA™ Synergy, EMG LivePlayTM software. The data were filtered in the 0.1-4 Hz 
frequency range and the sampling frequency was set at 20 Hz. The analyzed EMG parameters 
were: median frequency (MF) and median amplitude (MA) of the recorded AP. The example 
of detected AP is presented in Figure 1.  
All women had a follow up appointment after 7 days. The results were known to principal 
investigators only (OG, RM and OV) and the course of pregnancy was unaltered based on the 
obtained results.  
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MaCorr software (Sample size calculator, MaCorr Inc., Toronto, Ontario, Canada) was used 
for sample size calculation. Confidence interval (CI) was determined using the confidence 
level (CL) of 95%. The program has calculated that CI is 6.5%. Using CL of 95% and CI of 
6.5% the program has calculated that for population of low risk pregnant women the sample 
size needs to be 228.  
Statistical analysis of the maternal age, gestational age at the examination and BMI was 
performed using the Student t - test for independent variable (SPSS v11.0, SPSS Inc., Chicago 
IL, USA). Because the data of frequency and amplitude of AP were skewed, 1st quartile – 3rd 
quartile and median values were reported. Comparison of MF and MA values between the 
two groups was made with the Fisher exact test (SPSS v11.0, SPSS Inc., Chicago IL, USA). P 
< 0.05 was considered to be statistically significant. 
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Results 
Among 56/251 women with detected AP (APG 33/56 versus PPG 23/56) we found no 
statistically significant differences in MF (APG 0.022 Hz [0.014 – 0.032] vs. PPG 0.019 Hz 
[0.011 – 0.026], p = 0.527, Fisher exact test) and MA (APG 1500 mV [1000 – 2000] vs. PPG 
1500 mV [875 – 2000], p = 0.255, Fisher exact test). 
The comparison between the two groups is presented in Table 1.  
The average gestational age at the time of examiation was 19.6 weeks; 95%CI [18.9 – 20.4]  , 
the average BMI was 22.1 kg/m2; 95%CI [21.5 – 24] and average maternal age was 29.1  
years; 95%CI [26.4 – 31.4]. The differences among assessed paramaters between APG and 
PPG were not statistically significant. 
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Comment 
In this study we analyzed the EMG activity in low risk population of pregnant women in mid 
trimester of pregnancy. We are aware that majority of studies that investigated the effect of 
placental location on uterine electrical activity were performed in later gestation, particularly 
during the labor [2, 10]. However, our intention was to analyze potential difference in uterine 
electrical activity regarding the placental implantation site in mid trimester of pregnancy. 
Such difference in EMG measured parameters may potentially be used as a screening test for 
LSM and PTL.  
Transabdominal uterine EMG technique is simple, providing ethically acceptable method for 
better understanding of uterine physiology. As there is still an open question about artifacts 
resulting from muscular activity of the abdominal wall and internal organs we opted for MF 
measurements. Median frequency was considered to be a better assessment parameter than 
MA, as it is not so dependent on the type and quality of the tissue [10]. Furthermore, MF is 
simple, relatively easy to obtain and widely used in studies assessing uterine electrical activity 
[8, 10]. 
The anterior uterine wall is the major origin of the EMG activity detected trough the 
abdominal wall during pregnancy [10, 11]. In pregnant women with no contractions EMG 
activity represents the background uterine electrical activity [1, 11].  In some studies it was 
reported that anterior placental implantation could reduce the EMG uterine activity due to the 
placental hormonal inhibitory influence on the surrounding myometrial cells [10, 11].  
Several decades ago, Jung tested the electrical activity of the uterus above the placental 
implantational site and he was unable to detect it [12]. Marque et al. found a difference in the 
EMG uterine activity during the labor regarding anterior or posterior placental implantation, 
pointing out that the local placental hormones could decrease the EMG activity [11]. Gondry 
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et al. monitored 8 patients, 4 with anterior and 4 with posterior placental implantation, and 
found no significant difference in the recorded EMG activity between the two groups [9].  
Kavsek et al. found no significant difference in the EMG activity of the uterus in last trimester 
of pregnancy in patients without contraction, regarding the placental implantation site. 
However, comparing women with contractions, they found a significant difference in the 
EMG activity in women with anterior compared to posterior placental implantation. The 
patients with anterior placental implantational site had higher MF value [10]. 
In our study we found that placental implantation site alone does not change the uterine EMG 
activity in asymptomatic women, registered trough the abdominal wall in mid trimester. This 
may support the theory that in the presence of contractions, particularly during labor, 
hormonal changes in the placenta influence the electrical activity of myometrial cells above 
the placental implantation site [10, 11]. Again, it should be kept in mind that our results were 
obtained in the mid trimester when basic uterine activity is lower compared to later gestation. 
Pregnant women included in the study had no contractions during examination as well as at 
the follow up examination 7 days later. Since there was no statistically significant difference 
in MF and MA between two investigated groups, it can be suspected that relationship between 
uterine contractions and hormonal inhibitory influence of the placenta on the surrounding 
myometrial cells exists. This observation may have implications for better understanding of 
uterine physiology in pregnancy, and could be used in designing study protocols for further 
investigations.  
Although this was a relatively small study with negative conclusions, we believe placental 
implantation site has no effect on EMG results. Therefore, placental implantation site should 
not be considered while designing protocols for detection of potential “risk” group for PTL 
and LSM using transabdominal EMG. 
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Table 1.  
The comparison between groups with positive action potentials regarding the placental 
implantation site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: n – number of patients, GAE – gestational age at examination, BMI – body 
mass index, MF – median frequency, MA – median amplitude 
 
Numbers are: *mean [95% confidence interval] 
  **median [1st quartile – 3rd quartile] 
 
Statistical significance was obtained by Student t-test * or Fisher exact test ** as appropriate 
for given variable. 
 
 
 
 
 
 
 
 
 
 
 Anterior placenta     
group 
Posterior placenta 
group 
    
   p 
n 33/56 23/56  
Age (years)* 
 
29.8 [27.1 - 32.6] 
 
 
28.5 [25.8 - 30.2] 
 
 
0.574 
 
GAE (weeks)* 
   
19.9 [19.2 – 20.6] 
 
 
19.3 [18.6 – 20.1] 
 
0.301 
BMI (kg/m2)* 
 
22 [21.4 – 23.8] 
 
 
22.2 [21.7 – 24.1] 
 
0.471 
MF (Hz)** 0.022 [0.014 - 0.032] 
 
0.019 
[0.011 - 0.026] 
 
0.527 
MA (mV)** 
 
1500 
[1000 - 2000] 
 
 
1500 
[875 – 2000] 
 
0.255 
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Figure 1.  
 
Uterine action potential detected by transabdominal EMG  
 
 
 
 
 
 
 
 
 
 
 
 
